(Q43553173)

24 November 2017

title

Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression (English)

1 reference

24 November 2017

1 reference

Maluccio M

1

1 reference

24 November 2017

Sharma V

2

1 reference

24 November 2017

Lagman M

3

1 reference

24 November 2017

Konijn G

4

1 reference

24 November 2017

Suthanthiran M

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Transplantation Proceedings

24 November 2017

published in

1 reference

24 November 2017

volume

33

1 reference

24 November 2017

issue

1-2

1 reference

24 November 2017

page(s)

1820-1821

1 reference

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902696-8

7 January 2021

Stimulation of transforming growth factor-beta 1 transcription by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902696-8

7 January 2021

Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902696-8

7 January 2021

Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902696-8

7 January 2021

Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902696-8

7 January 2021

10.1016/S0041-1345(00)02696-8

Identifiers

DOI

1 reference

24 November 2017

1 reference